Scailyte
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
420 Broadway, Cambridge, Massachusetts, ...Phone Number
+41 445869660Website
www.scailyte.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Scailyte
Scailyte AG is a spin-off of ETH Zurich and combines single-cell technologies, high-quality datasets and machine learning methods to identify disease-specific biomarkers, with a focus on oncology and immunology. Scailyte's proprietary best-in-class data analysis platform ScaiVision associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, in order to identify ultra-sensitive biomarker signatures. Thanks to the single-cell resolution and AI-driven approach, ScaiVision is the most powerful and cutting-edge approach to develop methods for precise diagnosis and prediction of therapy response. Scailyte leverages a global network of clinicians to identify disease indications with high unmet needs and collaborates with global pharmaceutical and biotech companies to translate the novel biomarkers into ultra-sensitive companion diagnostics (CDx) and IVD assays.Explore more
Scailyte Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Scailyte your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Scailyte launches new products
Earning: See what the market has to say on Scailyte recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Scailyte has new funding data
Scailyte, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Scailyte is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Scailyte
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Scailyte has recently received funding, and reach out quickly before it becomes old news!
Click to see if Scailyte had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Scailyte
Find 3 more new buyers
Compare Similar Companies to Scailyte
Compare insights from companies similar to Scailyte, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Scailyte is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Scailyte is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Scailyte.
Scailyte financials insights
Gather financial insights about Scailyte, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Angel/Seed
$2.9M
Scailyte Tech Stack
A closer look at the technologies used by Scailyte
Most Recent Scoops
Event
Events
Funding
Funding
Funding
Scailyte News & Media
Swiss AI company Scailyte sells Endometriosis diagnostic assets to Hera Biotech
This week sees Scailyte, a Swiss company specialising in single-cell and AI-guided biomarker discovery, sign an agreement with US Hera Biotech, which will acquire the startup’s endometriosis diagnosti...Hera Biotech to Make First Acquisition in the Endometriosis Diagnostic Market and Enter Into Strategic Partnership With Scailyte
SAN ANTONIO & BASEL, Switzerland--(BUSINESS WIRE)-- #ai--Hera Biotech announced today that it has reached an agreement to acquire the endometriosis diagnostic assets and associated IP of single-cell and AI-driven biomarker discovery company Scailyte, creating an important consolidation of the only two tissue-based diagnostic programs for endometriosis. Endometriosis is a highly prevalent and debilitating disease with severe health-economic impact that contributes to a large majority of female inScailyte Announces Jan Lichtenberg, CEO at inSphero, as a Member of the Board of Directors
Scailyte, a biomarker discovery company leveraging single-cell omics and artificial intelligence, is proud to announce the appointment of Jan Lic ...Scailyte Announces Collaboration With Turnstone Biologics to Identify Biomarker Signatures in Solid Tumors With TIL Therapy
Scailyte AG, an ETH Zürich spin-off with a proprietary analytical sequencing, and data analysis platform to draw insights into complex disease pa ...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Scailyte
Sign Up For FreeTo access detailed company insights
Scailyte AG is a spin-off of ETH Zurich and combines single-cell technologies, high-quality datasets and machine learning methods to identify disease-specific biomarkers, with a focus on oncology and immunology. Scailyte's proprietary best-in-class data analysis platform ScaiVision associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, prot... Read More
